Mahindra Mohan is an accomplished professional whose expertise lies in the fields of biotechnology, corporate strategy, and business development. He studied Biology and Business at Cornell University and has worked in various organizations holding senior-level positions.

Currently serving as Associate Director, Hematology Early Asset Strategy & ULTOMIRIS Subcutaneous Commercial Lead at Alexion Pharmaceuticals, Inc., he has been instrumental in shaping the launch plans of new products and ensuring their commercial success. His experience in corporate strategy and business development has also been gained from his previous position at Achillion Pharmaceuticals, Inc.

Prior to these endeavors, he worked as a Senior Analyst at QuintilesIMS and as an Associate at TribalVision. He has also gained research experience working as a Research Associate at Cornell University and as a Land Surveyor at Pronesti Surveying Inc. Overall, Mahindra Mohan possesses a wealth of experience within the biotech industry and leverages his skills to drive growth and innovation.